- Home
- CRNX vs HHH Comparison
CRNX vs HHH Comparison
Compare CRNX & HHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNX
- HHH
- Stock Information
- Founded
- CRNX 2008
- HHH 2010
- Country
- CRNX United States
- HHH United States
- Employees
- CRNX N/A
- HHH N/A
- Industry
- CRNX Biotechnology: Pharmaceutical Preparations
- HHH Real Estate Investment Trusts
- Sector
- CRNX Health Care
- HHH Real Estate
- Exchange
- CRNX Nasdaq
- HHH Nasdaq
- Market Cap
- CRNX 2.8B
- HHH 3.3B
- IPO Year
- CRNX 2018
- HHH N/A
- Fundamental
- Price
- CRNX $30.40
- HHH $75.71
- Analyst Decision
- CRNX Strong Buy
- HHH Buy
- Analyst Count
- CRNX 7
- HHH 2
- Target Price
- CRNX $74.33
- HHH $80.50
- AVG Volume (30 Days)
- CRNX 1.0M
- HHH 366.7K
- Earning Date
- CRNX 08-07-2025
- HHH 08-06-2025
- Dividend Yield
- CRNX N/A
- HHH N/A
- EPS Growth
- CRNX N/A
- HHH N/A
- EPS
- CRNX N/A
- HHH 4.43
- Revenue
- CRNX $1,392,000.00
- HHH $1,770,945,000.00
- Revenue This Year
- CRNX $489.51
- HHH N/A
- Revenue Next Year
- CRNX $661.93
- HHH $22.53
- P/E Ratio
- CRNX N/A
- HHH $17.08
- Revenue Growth
- CRNX 0.51
- HHH 80.45
- 52 Week Low
- CRNX $24.10
- HHH $61.41
- 52 Week High
- CRNX $62.53
- HHH $87.77
- Technical
- Relative Strength Index (RSI)
- CRNX 53.04
- HHH 64.14
- Support Level
- CRNX $28.73
- HHH $74.75
- Resistance Level
- CRNX $31.70
- HHH $75.60
- Average True Range (ATR)
- CRNX 1.29
- HHH 1.41
- MACD
- CRNX 0.25
- HHH 0.27
- Stochastic Oscillator
- CRNX 77.85
- HHH 97.49
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
About HHH Howard Hughes Holdings Inc.
Howard Hughes Holdings Inc owns, manages, and develops commercial, residential, and mixed-use real estate throughout the USA. Its portfolio is strategically positioned to meet and accelerate development based on market demand, resulting in one of the strongest real estate platforms in the country. It operates through four business segments: Operating Assets, MPCs, Strategic Developments and Seaport.